RENE GONZALEZ to Clinical Trials, Phase II as Topic
This is a "connection" page, showing publications RENE GONZALEZ has written about Clinical Trials, Phase II as Topic.
Connection Strength
0.107
-
Efficacy and safety of HLA-B7/beta-2 microglobulin plasmid DNA/lipid complex (Allovectin-7) in patients with metastatic melanoma. Expert Opin Biol Ther. 2003 Apr; 3(2):377-84.
Score: 0.051
-
Efficacy and Safety Outcomes in Patients With Advanced Melanoma Who Discontinued Treatment With Nivolumab and Ipilimumab Because of Adverse Events: A Pooled Analysis of Randomized Phase II and III Trials. J Clin Oncol. 2017 Dec 01; 35(34):3807-3814.
Score: 0.035
-
Serial monitoring of circulating tumor cells predicts outcome of induction biochemotherapy plus maintenance biotherapy for metastatic melanoma. Clin Cancer Res. 2010 Apr 15; 16(8):2402-8.
Score: 0.021